logo
ResearchBunny Logo
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial

Medicine and Health

An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial

A. Saraf, R. Gurjar, et al.

This multicenter study explored the safety and effectiveness of the Omicron-specific GEMCOVAC-OM vaccine as a booster for adults previously vaccinated with BBV152 or ChAdOx1 nCoV-19. With promising results showing enhanced immunity against the B.1.1.529 variant, this research was conducted by a team of experts including Amit Saraf and Rohan Gurjar from Gennova Biopharmaceuticals Limited.

00:00
00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny